Scribd Logo
Upload

Welcome to Scribd!

  • Market Research Report :coronary Stents Market in India 2013

    Uploaded by

    Netscribes, Inc.
    22 views21 pages
    For the complete report, get in touch with us at : info@netscribes.com Abstract: Netscribes’ latest market research report titled Coronary stents Market in India 2013 states that manufacturers of coronary stents are experiencing high demand for their products due to a number of factors. Since cardiovascular diseases have become a common occurrence among the Indian population and the healthcare infrastructure in the country is rapidly improving, it has built a strong case for angioplasty procedures in the country. Moreover, an increase in awareness and the willingness to spend on healthcare is benefiting the market. Also, advancements in technology such as the introduction of bioabsorbable stents in the Indian market in December 2012 has made such stents more acceptable to patients, thereby providing further stimulus for market growth. With growth in the number of cath labs in the country and their subsequent expansion to smaller cities and towns, angioplasties will become more accessible to patients and will aid in further development of the market. Products available in the market can be divided into two types – those manufactured by MNCs that command high prices, and those manufactured by domestic companies that are generally priced lower. It is the MNCs that serve the majority of the market with almost all the big hospitals in tier I cities, where most of the angioplasties are performed, preferring to implant stents manufactured by foreign companies over those manufactured by their Indian counterparts. The general perception is that stents manufactured by MNCs are superior in terms of quality and efficacy, whereas those manufactured by domestic companies fail to attain similar high standards of quality. Also, patients are generally unaware of the choices they have in terms of the types of stents and the various brands that are available in the market, and have to buy stents directly from the hospitals. Since profit margins are higher in case of foreign-manufactured stents, hospitals push for the sale of such stents rather than selling the Indian varieties. Table of Contents: Slide 1: Executive Summary Macroeconomic Indicators Slide 2: GDP at Factor Cost: Quarterly (2009-10, 2010-11, 2011-12, 2012-13), Inflation Rate: Monthly (Nov 2012 – Apr 2013) Slide 3: Gross Fiscal Deficit: Monthly (Sep 2011-Feb 2012), Exchange Rate: Monthly (Dec 2012 – May 2013) Slide 4: Lending Rate: Annual (2009-10, 2010-11, 2011-12, 2012-13), Trade Balance: Annual, FDI: Annual (2009-10, 2010-11, 2011-12, 2012-13) Introduction Slide 5: Coronary stents – Uses, Characteristics and Types Slide 6: Development of Coronary Stents Market Overview Slide 7: Angioplasties – Overview and Number of Procedures Performed in India (2009 – 2017e) Slide 8: Coronary Stents – Market Overview, Market Size & Growth (Value-Wise; 2011 – 2017e & Volume-Wise; 2011 – 2017e) Slide 9: Drug-Eluting Stents – Market Overview, Market Size & Growth (Value-Wise; 2011 – 2017e & Volume-Wise; 2011

    Original Title

    Market Research Report :Coronary stents market in india 2013

    Copyright

    © Attribution Non-Commercial (BY-NC)

    Available Formats

    PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Report this Document
    For the complete report, get in touch with us at : info@netscribes.com Abstract: Netscribes’ latest market research report titled Coronary stents Market in India 2013 states that manufacturers of coronary stents are experiencing high demand for their products due to a number of factors. Since cardiovascular diseases have become a common occurrence among the Indian population and the healthcare infrastructure in the country is rapidly improving, it has built a strong case for angioplasty procedures in the country. Moreover, an increase in awareness and the willingness to spend on healthcare is benefiting the market. Also, advancements in technology such as the introduction of bioabsorbable stents in the Indian market in December 2012 has made such stents more acceptable to patients, thereby providing further stimulus for market growth. With growth in the number of cath labs in the country and their subsequent expansion to smaller cities and towns, angioplasties will become more accessible to patients and will aid in further development of the market. Products available in the market can be divided into two types – those manufactured by MNCs that command high prices, and those manufactured by domestic companies that are generally priced lower. It is the MNCs that serve the majority of the market with almost all the big hospitals in tier I cities, where most of the angioplasties are performed, preferring to implant stents manufactured by foreign companies over those manufactured by their Indian counterparts. The general perception is that stents manufactured by MNCs are superior in terms of quality and efficacy, whereas those manufactured by domestic companies fail to attain similar high standards of quality. Also, patients are generally unaware of the choices they have in terms of the types of stents and the various brands that are available in the market, and have to buy stents directly from the hospitals. Since profit margins are higher in case of foreign-manufactured stents, hospitals push for the sale of such stents rather than selling the Indian varieties. Table of Contents: Slide 1: Executive Summary Macroeconomic Indicators Slide 2: GDP at Factor Cost: Quarterly (2009-10, 2010-11, 2011-12, 2012-13), Inflation Rate: Monthly (Nov 2012 – Apr 2013) Slide 3: Gross Fiscal Deficit: Monthly (Sep 2011-Feb 2012), Exchange Rate: Monthly (Dec 2012 – May 2013) Slide 4: Lending Rate: Annual (2009-10, 2010-11, 2011-12, 2012-13), Trade Balance: Annual, FDI: Annual (2009-10, 2010-11, 2011-12, 2012-13) Introduction Slide 5: Coronary stents – Uses, Characteristics and Types Slide 6: Development of Coronary Stents Market Overview Slide 7: Angioplasties – Overview and Number of Procedures Performed in India (2009 – 2017e) Slide 8: Coronary Stents – Market Overview, Market Size & Growth (Value-Wise; 2011 – 2017e & Volume-Wise; 2011 – 2017e) Slide 9: Drug-Eluting Stents – Market Overview, Market Size & Growth (Value-Wise; 2011 – 2017e & Volume-Wise; 2011

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content
    Download as pdf or txt
    22 views21 pages

    Market Research Report :coronary Stents Market in India 2013

    Uploaded by

    Netscribes, Inc.
    For the complete report, get in touch with us at : info@netscribes.com Abstract: Netscribes’ latest market research report titled Coronary stents Market in India 2013 states that manufacturers of coronary stents are experiencing high demand for their products due to a number of factors. Since cardiovascular diseases have become a common occurrence among the Indian population and the healthcare infrastructure in the country is rapidly improving, it has built a strong case for angioplasty procedures in the country. Moreover, an increase in awareness and the willingness to spend on healthcare is benefiting the market. Also, advancements in technology such as the introduction of bioabsorbable stents in the Indian market in December 2012 has made such stents more acceptable to patients, thereby providing further stimulus for market growth. With growth in the number of cath labs in the country and their subsequent expansion to smaller cities and towns, angioplasties will become more accessible to patients and will aid in further development of the market. Products available in the market can be divided into two types – those manufactured by MNCs that command high prices, and those manufactured by domestic companies that are generally priced lower. It is the MNCs that serve the majority of the market with almost all the big hospitals in tier I cities, where most of the angioplasties are performed, preferring to implant stents manufactured by foreign companies over those manufactured by their Indian counterparts. The general perception is that stents manufactured by MNCs are superior in terms of quality and efficacy, whereas those manufactured by domestic companies fail to attain similar high standards of quality. Also, patients are generally unaware of the choices they have in terms of the types of stents and the various brands that are available in the market, and have to buy stents directly from the hospitals. Since profit margins are higher in case of foreign-manufactured stents, hospitals push for the sale of such stents rather than selling the Indian varieties. Table of Contents: Slide 1: Executive Summary Macroeconomic Indicators Slide 2: GDP at Factor Cost: Quarterly (2009-10, 2010-11, 2011-12, 2012-13), Inflation Rate: Monthly (Nov 2012 – Apr 2013) Slide 3: Gross Fiscal Deficit: Monthly (Sep 2011-Feb 2012), Exchange Rate: Monthly (Dec 2012 – May 2013) Slide 4: Lending Rate: Annual (2009-10, 2010-11, 2011-12, 2012-13), Trade Balance: Annual, FDI: Annual (2009-10, 2010-11, 2011-12, 2012-13) Introduction Slide 5: Coronary stents – Uses, Characteristics and Types Slide 6: Development of Coronary Stents Market Overview Slide 7: Angioplasties – Overview and Number of Procedures Performed in India (2009 – 2017e) Slide 8: Coronary Stents – Market Overview, Market Size & Growth (Value-Wise; 2011 – 2017e & Volume-Wise; 2011 – 2017e) Slide 9: Drug-Eluting Stents – Market Overview, Market Size & Growth (Value-Wise; 2011 – 2017e & Volume-Wise; 2011

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content
    Download as pdf or txt
    of 21

    Insert Cover Image using Slide Master View Do not distort

    Coronary Stents Market India


    October 2013

    Executive Summary
    Market
    Coronary stents market in India is expected to grow at a CAGR of x1%% over 2011 - 2017e There are three types of coronary stents available in the market, bare metal stents (BMS), drugeluting stents (DES), and bioabsorbable stents Drivers: Challenges:
    Problems associated with usage Constant need for innovation and new product development Increasing lifestyle based diseases Improving health infrastructure Changing demographics Increased healthcare spending and insurance coverage Advancements in technology and medical procedures

    Drivers & Challenges

    Government Involvement Competitive Landscape Buyer Details

    Regulatory Bodies Regulatory Policies Regulatory Processes Major Foreign Companies


    Company 1 Company 2

    Major Domestic Companies


    Company 3 Company 4 Company 5 Company 6

    Top Hospitals Buying Coronary Stents in India


    Hospital 1 Hospital 2 Hospital 3 Hospital 4 Hospital 5 Hospital 6

    CORONARY STENTS MARKET IN INDIA 2013.PPT

    Economic Indicators Introduction Market Overview Drivers & Challenges Government Involvement
    Regulatory Bodies Regulatory Policies Regulatory Processes

    Competitive Landscape Buyer Details Recent Developments Strategic Recommendations Appendix


    CORONARY STENTS MARKET IN INDIA 2013.PPT

    Economic Indicators (1/3)


    GDP at Factor Cost: Quarterly
    INR tn 14 13 12 11 10 Q1 Q2 2009-10 2010-11 2011-12 Q3 2012-13 Q4 a1 b1 c1 d1 a2 b2 c2 d2 b3 c3 d3 b4 c4 d4

    Inflation Rate: Monthly


    %
    1.0 0.8 0.6 0.4 0.2 0.0

    Nov 2012 - Dec 2012

    Dec 2012 - Jan 2013

    Jan 2013 - Feb 2013

    Feb 2013 - Mar 2013

    Mar 2013 - Apr 2013 4

    SANITARYWARE MARKET IN INDIA 2013.PPT

    Indian market for coronary stents is poised to grow in the coming years with emphasis on drug-eluting stents
    Coronary Stents Market Overview

    Indian market for coronary stents is expected to show steady growth in coming years, providing strong opportunities to present and potential players to earn high revenues and increase their profits There are three types of coronary stents available in the market, bare metal stent, drug-eluting stents and bioabsorbable stents Type Y stents experience the highest demand while Type Z stents are still at a nascent stage

    Market Size and Growth (Value-Wise)


    Type 1 Type 2 Type 3 h x1% c a a1% a2% 2011 b b1% b2% 2012 c1% c2% c3% 2013e d d1% d2% d3% 2014e f f1% f2% g1% g2% g3% 2016e h1% g

    Market Size and Growth (Volume-Wise)


    Type 1 Type 2 Type 3 v x2% t q q1% q2% 2012 r r1% r3% r2% s s1% s2% s3% 2014e t1% t2% u1% v1% u

    INR bn
    40 30 20 10 0

    000
    600 500 400 300 200 100 0

    p p1% p2% 2011

    f3%

    h2% h3% 2017e

    t3%

    u2% u3% 2016e

    v2% v3% 2017e

    2015e

    2013e

    2015e

    CORONARY STENTS MARKET IN INDIA 2013.PPT

    Prices vary not only across stent types but also depending on whether it is indigenously manufactured or is foreign made
    Coronary Stents Price Trends

    Type of stent

    Indigenous /Foreign

    Price (INR)

    Remarks
    These are price at which distributors purchase from manufacturers When hospitals procure stents directly from manufacturers, they can get up to x% discounts Price at which distributors supply the stents to hospitals Difficult for hospitals to procure directly from manufacturers as these stents are manufactured outside India Price at which distributors purchase from manufacturers Hospitals can get discounts on these price by purchasing directly from the manufacturer Price to the end-user, that is, the patients Distributors can procure the lower priced, foreign made DES for as little as INR a Was priced INR u when it was launched in Dec 2012 Presently, Abbott has monopoly on these stents but in future as more companies produce these stents, the price is expected to fall

    Bare Metal

    Indigenous

    Bare Metal

    Foreign

    Drug-Eluting

    Indigenous

    Drug-Eluting

    Foreign

    Bioabsorbable

    Foreign

    CORONARY STENTS MARKET IN INDIA 2013.PPT

    Drivers & Challenges Summary

    Drivers
    Increasing lifestyle based diseases Improving health infrastructure Changing demographics Increased healthcare spending and insurance coverage Advancements in technology and medical procedures

    Challenges
    Problems associated with usage Constant need for innovation and new product development

    CORONARY STENTS MARKET IN INDIA 2013.PPT

    Regulation of medical devices such as stents are done through different divisions under the MoHFW
    Organizational Structure Level 1

    Level 2

    Level 3

    Level 4

    Level 5

    Level 6A

    Level 6B

    Level 7A

    Level 7B

    Level 7C

    Level 7D

    CORONARY STENTS MARKET IN INDIA 2013.PPT

    Although there isnt any specific legislation governing the entire medical devices industry, certain devices are
    Regulatory Bodies (1/2)

    Regulatory Body A Regulatory Body A is the main body for the regulation of pharmaceuticals and medical devices in India Within Regulatory Body A, Entity B is responsible for the regulating pharmaceuticals and medical devices and is advised by Body C and Body D It is responsible for establishing the safety, efficacy, and quality standards for pharmaceuticals and medical devices A list of regulated pharmaceuticals and devices, Indian Pharmacopeia, is published and updated by Regulatory Body A It also appoints notified bodies for conducting conformity assessment procedures including tests for all drug and device applications to ensure that it complies with all standards set by the body Regulatory Body A is also divided into several zonal offices which conduct the pre-licensing and post-licensing inspections, post-market surveillance, and recalls whenever necessary Apart from the regulatory functions, Regulatory Body A also offers technical guidance and trains regulatory officials and analysts as well as monitors adverse events Regulatory Body A also works with the World Health Organization to promote Good Manufacturing Practice (GMP)

    CORONARY STENTS MARKET IN INDIA 2013.PPT

    Market for coronary stents in India is dominated by products from foreign companies
    Competition Overview MNCs have a dominant share in the coronary stents market in India Products from MNCs are generally viewed as superior to those manufactured by domestic companies
    As a result of this, there is a higher uptake of products from foreign companies while Indian manufacturers find it difficult to get buyers for their products Even Company Y which exited the stents business in mid 2011, commanded u% share of the market in 2012 through its products that were stored as inventory

    Market Share Volume-Wise (2012)


    Company 1 Company 2 Company 3 Company 4 Company 5 Company 6 Others

    h%

    a%

    Company 1, company 2 and Company 3 together account for ~m% of the market in terms of volume and n% of the market in terms of value Company 1 is the clear leader in the market with a% share in volume terms, followed by Company 2

    g% f% d% c% b%

    CORONARY STENTS MARKET IN INDIA 2013.PPT

    10

    Competitive Benchmarking Private Companies (1/4)


    Key Ratios of Major Private Companies Operational Basis (FY 2012) (1/3)
    Operating Margin Net Margin

    %
    100 50 0 -50 -100

    a2

    b2

    a3

    a4 b3 b4

    -a1

    -b1 Company 2 Company 3 Company 4

    Company 1

    Company 4 recorded operating margin of a4%, higher than that of Company 3, Company 2 and company 1 which recorded operating margin of a3%, a2% and a1% respectively Net margin was highest for Company 3 at b3%%, followed by Company 4 which recorded a net margin of b4% Company 1 which recorded a negative net margin of a1% had the lowest net margin amongst its peers

    CORONARY STENTS MARKET IN INDIA 2013.PPT

    11

    Private: Foreign Company Company 1 (1/5)


    Company Information
    Corporate Address Tel No. Fax No. Website Year of Incorporation

    Offices and Centres India

    Mumbai

    Products and Services


    Products/Services

    Head Office

    Key People
    Name Person 1 Person 2 Person 3 Designation Director Director Director

    CORONARY STENTS MARKET IN INDIA 2013.PPT

    12

    Private: Foreign Company Company 1 (2/5)


    Shareholders of the Company as on 27/06/2013
    Name No. of Shares held

    Ownership Structure
    Foreign Holdings

    100.00%

    CORONARY STENTS MARKET IN INDIA 2013.PPT

    13

    Private: Foreign Company Company 1 (3/5)


    Financial Snapshot
    Total Income INR bn 30 25 20 15 10 5 0 a1 2008 c1 b1 2009 2010 2011 d2 d1 a2 b2 c2 Net Profit / Loss INR bn 5 0 -5 -10 -15 -20 -25

    Key Ratios
    Particulars y-o-y change (2011-10) 2011 2010 2009 2008

    Profitability Ratios
    Operating Margin Net Margin Profit Before Tax Margin Return on Equity Return on Capital Employed Return on Working Capital Return on Assets Return on Fixed Assets

    Cost Ratios
    Operating costs (% of Sales) Administration costs (% of Sales) Interest costs (% of Sales)

    Financial Summary
    Company earned a net profit of INR XX mn in FY 20XX, as compared to net profit of INR Y mn in FY 20YY It reported total Income of INR XX mn in FY 20XX, registering an increase of X per cent over FY 20YY It earned an operating margin of X.X per cent in FY 20XX an increase of X.X percentage points over FY 20YY The company reported debt to equity ratio of X.XX in FY 20XX, an increase of X.X per cent over FY 20YY

    Liquidity Ratios
    Current Ratio Cash Ratio

    Leverage Ratios
    Debt to Equity Ratio Debt to Capital Ratio Interest Coverage Ratio

    Efficiency Ratios
    Fixed Asset Turnover Asset Turnover Current Asset Turnover Working Capital Turnover Capital Employed Turnover
    Improved Decline

    CORONARY STENTS MARKET IN INDIA 2013.PPT

    14

    Private: Foreign Company Company 1 (4/5)


    Business Highlights
    Description Overview News Company 1 operates in the Segment 1, Segment 2, segment 3 and Segment 4 It was previously the domestic formulations business of Company Y and was renamed as Company 1 after it was acquired by Company Z in 20- It has a formulation facility at City 1, State 1 where a Product A is manufactured However, coronary stents sold by the company in India are manufactured by various subsidiaries of the parent company, company Z A number of models of coronary stents from the company are available in India Model 1 Carotid Stent System and Model 2 Coronary Stent marketed by the company are manufactured by Company A, City 2, Country 2 Model 3 Coronary Stent System and Model 4 series are manufactured by Company B, City 3, Country 3 Model 5 Stent System is manufactured by Company C in its manufacturing facility at City 4, Country 4 Everolimus Eluting Model 6, Model 7, Model 8, Model 9, Model 10 and Model 11 are manufactured by Company B Model 12 stent system are manufactured by Company D, Country 5

    Manufacturing Facility

    Coronary Stents Products

    CORONARY STENTS MARKET IN INDIA 2013.PPT

    15

    Private: Foreign Company Company 1 SWOT Analysis (5/5)

    S O

    W T

    CORONARY STENTS MARKET IN INDIA 2013.PPT

    16

    Buyer Snapshot: List of Top 10 Buyers of Coronary Stents


    Top 10 hospitals buying coronary stents in India Hospital Name Hospital 1 Hospital 2 Hospital 3 Hospital 4 Hospital 5 Hospital 6 Hospital 7 Hospital 8 Hospital 9 Hospital 10 Hospital Logo Hospital Chain Ownership Type Angioplasty Procedures Per Month

    CORONARY STENTS MARKET IN INDIA 2013.PPT

    17

    Public: Domestic Company Hospital 1 (1/3)


    Company Information
    Corporate Address

    Head Office and Hospital Network India

    Tel No. Fax No. Website Year of Incorporation

    Products and Services


    Category Products/Services Head Office Hospital Network

    Key People
    Name Person 1 Person 2 Person 3 Person 4 Designation President (Institute Body) Dean Director Medical Superintendent

    CORONARY STENTS MARKET IN INDIA 2013.PPT

    18

    Public: Domestic Company Hospital 1 (2/3)


    Business Highlights
    Description News Is a group of m hospitals across India Has p teaching departments and centers Has a total of x beds There are y doctors and z nurses Leader in Therapy 1 It has India's first and only Therapy A training centre It is a pioneer of Type A surgeries in India, particularly System 1 for Therapy 2, and System 2 Expansion plans of the hospital chain were recently approved by the Body 1

    Overview

    Facilities

    Future Plans

    CORONARY STENTS MARKET IN INDIA 2013.PPT

    19

    Public: Domestic Company Hospital 1 (3/3)


    Parameter
    Total cardiac patients per month Angioplasties per month Stent providers

    Hospital Indicators

    Purchase decision factors Stents procurement Contact Details Centralized/ Hospital level HOD/ Technician/ Procurement

    Procedure/ process involved in procurement Contact details purchase Stent Types

    Overview of Stent Procurement Process

    CORONARY STENTS MARKET IN INDIA 2013.PPT

    20

    Thank you for the attention


    Coronary Stents Market India report is part of Netscribes Healthcare Industry Series. For any queries or customized research requirements, contact us at:
    Phone: E-Mail: +91 22 4098 7600 info@netscribes.com

    Follow us on:

    About Netscribes, Inc. Netscribes, Inc. is a knowledge-consulting and solutions firm with clientele across the globe. The companys expertise spans areas of investment & business research, business & corporate intelligence, content-management services, and knowledge-software services. At its core lies a true value proposition that draws upon a vast knowledge base. Netscribes, Inc. is a one-stop shop designed to fulfil clients profitability and growth objectives. Disclaimer: This report is published for general information only. Although high standards have been used in the preparation, Netscribes is not responsible for any loss or damage arising from use of this document. This document is the sole property of Netscribes and prior permission is required for guidelines on reproduction.
    CORONARY STENTS MARKET IN INDIA 2013.PPT

    21

    You might also like